Biofourmis Raises $100M in Series C
Biofourmis has successfully raised $100M in a Series C at a $500M valuation led by SoftBank Vision Fund 2, Openspace Ventures.
Company Overview
Biofourmis is a HealthTech company headquartered in Boston, MA, founded in 2015 with 300+ employees.
AI-powered patient analytics platform
Fundraising Details
- Amount Raised: $100M
- Round Type: Series C
- Valuation: $500M
- Date: 2021-05-25
- Investors: SoftBank Vision Fund 2, Openspace Ventures
About Biofourmis
AI-powered patient analytics platform The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: Boston, MA
- Founded: 2015
- Team Size: 300+
- Industry: HealthTech
What This Means
This funding round demonstrates strong investor confidence in Biofourmis's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Biofourmis's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching a $500M valuation marks an important milestone for Biofourmis, positioning the company among notable players in the HealthTech industry.
Looking Ahead
With this new capital, Biofourmis is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
---
This fundraising news was reported on 2021-05-25. For more information about Biofourmis, visit their headquarters at Boston, MA.
